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A B S T R A C T
Background: Tick borne encephalitis (TBE) is an acute meningoencephalitis with or without myelitis
caused by an RNA virus from the ﬂavivirus family transmitted by Ixodes spp ticks. The neurotropic TBE
virus infects preferentially large neurons in basal ganglia, anterior horns, medulla oblongata, Purkinje
cells and thalamus. Brain metabolic changes related to radiologic and clinical ﬁndings have not been
described so far.
Methods: Here we describe the clinical course of 10 consecutive TBE patients with outcome assessment
at discharge and after 12 month using a modiﬁed Rankin Scale. Patients underwent cerebral MRI after
conﬁrmation of diagnosis and before discharge. 18F-FDG PET/CT scans were performed within day 5 to
day 14 after TBE diagnosis. Extended analysis of coagulation parameters by thrombelastometry
(ROTEM1 InTEM, ExTEM, FibTEM) was performed every other day after conﬁrmation of TBE diagnosis
up to day 10 after hospital admission or discharge.
Results: All patients presented with a meningoencephalitic course of disease. Cerebral MRI scans showed
unspeciﬁc ﬁndings at predilection areas in 3 patients. 18F-FDG PET/CT showed increased glucose
utilization in one patient and decreased 18F-FDG uptake in seven patients. Changes in coagulation
measured by standard parameters and thrombelastometry were not found in any of the patients.
Discussion: Glucose hypometabolism was present in 7 out of 10 TBE patients reﬂecting neuronal
dysfunction in predilection areas of TBE virus inﬁltration responsible for development of clinical signs
and symptoms.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Tick-borne encephalitis (TBE) is an acute meningoencephalitis
with or without myelitis caused by an RNA ﬂavivirus, transmitted
by Ixodes spp ticks from western Europe to the eastern coast of
Japan1,2.
Typically TBE has a characteristic biphasic clinical course. After
an initial incubation period of a median of 8 days signs and
symptoms like fever, fatigue, general malaise, headache and* Corresponding author. Department of Neurology Innsbruck Medical University
Anichstrasse 35 6020 Innsbruck, Austria.
E-mail address: anelia.dietmann@gmail.com (A. Dietmann).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).arthralgia occur followed by a symptom-free interval 3–5. Neuro-
logical manifestations hallmark the second stage ranging from
mild meningitis with headache, to severe meningoencephalitis
with impaired consciousness, epileptic seizures and, in severe
cases, coma
3
. About 10% of all patients develop a meningoence-
phalomyelitis with acute ﬂaccid paralysis and respiratory insufﬁ-
ciency requiring assisted ventilation3. The grade of severity in this
acute phase is associated with poor outcome. Overall, up to 46% of
patients suffer from long-term sequelae, such as headache,
memory impairment, tremor or ataxia one year after TBE 4,5, with
moderate to severe impairment of life quality in up to 30% of
patients 4.
MRI studies3,6–8 and histopathological examinations9–14
suggest an afﬁnity of the TBE virus for certain regions of theciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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cerebellum and brainstem with associated neurological signs
and symptoms such as tremor, ataxia, paresis and rigidity of
extremities. However, changes in cerebral MRI are only evident in
up to 18% of patients with TBE 3,6–8. Pathophysiologic mechanisms
leading to these clinical or radiological ﬁndings still remain
unclear.
The two aims of this pilot study were 1) to investigate cerebral
metabolic changes in TBE patients using [(18)F]2-deoxy-2-ﬂuoro-
D-glucose positron emission tomography (18F-FDG PET) in
combination with CT and to correlate these ﬁndings to clinical
signs and symptoms and outcome. 2) To evaluate subtle
coagulation changes by cell based rotational thrombelastometry
(ROTEM1).
2. Material and Methods
The study was approved by the IRB of the Medical University of
Innsbruck, Austria in (EK 01/2011).
Ten consecutive patients were enrolled prospectively after
signing written informed consent when diagnosis of TBE had been
conﬁrmed by serological testing as well as RT-PCR with a direct
Virus RNA detection in the patient’s blood. Patient’s clinical course
was followed and reported closely according to protocol.
Neurological signs and symptoms as well as standard laboratory
values including red and white blood cell count, thrombocyte
count, standard coagulation parameters (activated partial throm-
boplastin time, prothrombin time) were monitored according to
clinical routine. At time of discharge and 12 months thereafter
patients were evaluated by means of a modiﬁed Rankin Scale
(mRS)15. Follow up was performed by telephone interview
12 months after discharge.
2.1. Cerebral MRI Scan
According to the study protocol two 3 Tesla MRI scans (Verio,
Siemens, Erlangen, Germany) were performed after conﬁrmation
of the diagnosis and before discharge. For further description see
Supplementary Material.
2.2. [(18)F]2-deoxy-2-ﬂuoro-D-glucose positron emission
tomography (18F-FDG PET/CT)
18F-FDG PET/CT imaging was performed at day 9 (median, range
day 5 – 14) after hospital admission respectively day 14 (median,
range 6 – 22) after onset of TBE meningoencephalitis characteristic
signs and symptoms (onset of second peak in biphasic course of
7 patients and onset of ﬁrst symptoms in 3 patients presenting
without biphasic disease course). 18F-FDG PET/CT scans of theTable 1
Demographics and clinical features
Patient
No.
Sex Age
(years)
First onset
(days)
Bimodal
Course
Second
onset (days)
Leading neurolo
1 F 25 28 yes 1 Tremor, ataxia 
2 F 66 28 yes 7 Ataxia, rigid lim
3 F 29 28 yes 3 Epileptic seizure
4 M 72 21 yes 2 Cognitiv impairm
5 M 72 21 no 3 Gait disorder, he
6 M 80 11 no Opsoclosnus, my
status epilepticu
7 F 61 10 yes 1 Rigid limb tonus
8 M 66 10 no Headache, EEG c
9 M 51 21 yes 7 Headache, EEG c
10 M 70 14 yes 7 Somnolence, trem
F, female; M, male; First onset (days), Days from ﬁrst symptom onset until hospital admiss
if disease course was bimodal; mRS, modiﬁed Rankin Scale; mRS, Follow Up one year brain were performed, without intravenous contrast application
during the CT phase. Image interpretation was independently
performed by two experienced nuclear medicine specialists
blinded to clinical course and coagulation studies. In each of the
10 patients, regions of interest were deﬁned and characterized
according to the intensity of glucose utilization as glucose
hypermetabolic or glucose hypometabolic regions, in comparison
to the physiologic glucose metabolism of cerebral areas not
affected by the disease in PET/CT and MRI. For further description
see Supplementary Material.
2.3. Thrombelastometry
Extended analysis of coagulation parameters by thrombelas-
tometry (ROTEM1 InTEM, ExTEM, FibTEM) was performed every
other day after conﬁrmation of TBE diagnosis until day 10 after
hospital admission or until discharge.
2.4. Statistical analysis
Due to the pilot nature of the study and the small number of
enrolled patients statistics for 18F-FDG PET/CT and clinical data are
descriptive only. Comparisons of MRI perfusion in ROI were
performed by Kruskal-Wallis Test with Dunn’s post-hoc test. All
analyses were performed by Graph Pad Prism 5.
3. Results
3.1. Patient’s characteristics, clinical ﬁndings and outcome
Ten consecutive patients were enrolled from June 2011 until
September 2012, four females and six males with a median age of
65.5 years (range 24 – 79). A detailed description of patient’s
characteristics and relevant clinical ﬁndings as well as outcome is
given in Table 1. Only patients with a meningoencephalitic course
of the disease were enrolled, whereof in two patients headache
was the predominating clinical symptom, but both had moderate
to severe EEG ﬁndings suggesting encephalitis. In 3 patients a
Glasgow Coma Scale  9 during the course of disease in the
hospital was reported, one patient necessitated mechanical
ventilation due to bilateral paresis of nervus phrenicus. Median
time of hospital stay was 17 days (range 7 - 69). Six patients had
only mild symptoms without signiﬁcant disability at discharge,
two patients were slightly disabled and unable to carry out all
previous activities and one patient was severely disabled,
bedridden and required constant nursing care and attention
(Table 1). At follow up one year after TBE four patients still
reported mild symptoms such as hand tremor, headaches,
impaired ﬁne motor skills without disability to carry out allgic signs and symptoms Time in
Hospital (days)
mRS
Discharge
mRS
Follow up
10 1 1
b tonus, headache 17 1 na
s, cognitiv impairment 24 1 na
ent, depression 10 1 0
adache, somnolence 30 0 0
oclonus, coma, non convulsiv
s, mechanical ventilation
69 5 4
, cognitiv impairment, desoriented 28 2 1
hanges 7 2 1
hanges 14 1 0
or, cognitive impairment 17 1 1
ion; Second onset (days), Days from second symptom onset until hospital admission
after admission to hospital; na, Patients not assessable for mRS.
A. Dietmann et al. / International Journal of Infectious Diseases 51 (2016) 73–77 75usual duties and activities. One patient was still severely disabled,
unable to walk without assistance, unable to attend own bodily
needs without assistance and unable to attend a normal
conversation. Three patients reported no symptoms at all. Two
patients were lost for follow up, both had moved back to their
country of permanent residence and we failed to contact them in
time. However, both patients had shown a mRS 1 at hospital
discharge suggesting a further favorable course. Despite the
severity of disease all 10 patients survived.
3.2. Routine laboratory Parameters and ROTEM1
The median White Blood Cell Count was expectedly elevated at
10.950/ml (range 7.800 – 17.000/ml), the median hemoglobin level
was within the normal range of 134,5 g/l (range 95 – 177 g/l). One
patient had decreased thrombocyte count on admission (105.000/
ml) and the day after admission (96.000/ml). All other patients had
thrombocyte counts within the normal range (150.000 - 400.000/
ml) on admission and every other day of routinely performed
measurement of thrombocyte cell count. Activated partial
thromboplastin time was within normal range (28-40 sec) in all
10 patients (mean on admission 32  3.5 sec, mean overall patients
during hospitalization 34.7  4.5 sec). Prothrombin time was within
normal range in all 10 patients (mean on admission 94.6  14%, meanFigure 1. 18F-FDG PET/CT scans: (a, b) 25 year old patient suffering TBE with region of gluc
of glucose hypometabolism including the frontal lobe on both sides and (e, f) 80 year o
intubated and analgosedated previous to the scan.overall patients during hospitalization 86  11.2%; normal range 70-
120%, INR 1.0 – 1.3).
EXTEM, INTEM and FIBTEM every other day until day 10 of
hospitalization revealed no signiﬁcant impairment of coagulation
(detailed data not shown). In six patients FIBTEM showed elevated
maximal clot ﬁrmness due to hypoﬁbrinogenemia.
3.3. 18F-FDG PET/CT
One patient showed increased glucose utilization in the right
cerebellar hemisphere (ﬁgure 1). 6 patients showed decreased 18F-
FDG uptake in different brain regions such as bifrontal, fronto-
temporal left, temporopolar left, temporoparietal left, bitempor-
obasal, hippocampal left. One patient showed global decreased
18F-FDG uptake, however this patient has been intubated and
analgosedated previously to the scan. In 2 patients, no change of
18F-FDG uptake was seen on 18F-FDG PET/CT (detailed data shown
in Table 2, Supplementary Material).
3.4. MRI ﬁndings
Corresponding to literature MRI ﬁndings on admission were
uncharacteristic with diffuse and unspeciﬁc signal alterations in
the nucleus caudatus (n = 1), putamen (n = 1), nucleus dentatusose hypermetabolism to the right cerebellum, (c, d) 72 year old patient with a region
ld patient with global cerebral glucose hypometabolism, however, the patient was
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Comparison of MRI-perfusion in speciﬁc brain areas yielded no
signiﬁcant difference (Supplementary Material, Table 3). At
discharge MRI ﬁndings revealed no signiﬁcant change and were
unspeciﬁc in all patients.
4. Discussion
To our knowledge, this is the ﬁrst report on brain metabolic
changes using 18F-FDG PET/CT in a series of ten patients suffering
from meningoencephalitic course of TBE. We found a hypometa-
bolic glucose uptake pattern in 7 out of 10 TBE patients. One
patient showed a hypermetabolic 18F-FDG pattern in the right
cerebellum correlating with clinical ﬁndings of ataxia. Interest-
ingly, this patient was examined at the earliest time point after
onset of TBE speciﬁc signs and symptoms (day 6 vs. median
14 days). Therefore, it is tempting to speculate that cerebral
glucose metabolism might change with duration of disease. Early
glucose hypermetabolism has been related to active inﬂamma-
tion, while hypometabolism later in the course of disease might
be a sign of neuronal dysfunction or even neuronal loss
16,19,20. One patient had an impressive global hypometabolism,
however, during 18F-FDG PET/CT this patient was analgosedated
with midazolam and sufentanil. Therefore, a generalized
hypometabolic pattern is probable rather due to decreased
overall cerebral metabolism under analgosedation than speciﬁc
for TBE.
However, we were not able to demonstrate neither a TBE
speciﬁc glucose uptake pattern, a correlation between glucose
metabolism and clinical signs and symptoms nor brain MRI scan,
most likely to the small number of included patients.
Literature on cerebral metabolism in encephalitis or menin-
goencephalitis is limited; most publications are case reports only.
In the largest study so far on patients with clinically suspected
encephalitis 18F-FDG PET revealed glucose hypermetabolism in
most cases of deﬁnitive diagnosis of encephalitis in the acute
phase, however also hypometabolic patterns were found 16. Alavi
et al. described glucose hypometabolism with two different
patterns of either speciﬁc temporal lobe hypometabolism or a
diffuse cortical hypometabolism in 17 out of 24 patients with
conﬁrmed Lyme disease17. To our knowledge only one study
investigating regional cerebral blood ﬂow measured by SPECT has
been published on TBE so far 18, describing a moderately
decreased regional cerebral blood ﬂow with a patchy or
multifocal pattern in almost 50% of TBE patients. Findings were
more common in patients with encephalitis compared to
meningitis 18.
Members of the ﬂavivirus family such as yellow fever virus or
Dengue virus may cause hemorrhagic fever 23. Decreased
thrombocyte counts are frequently seen early in TBE virus
infection without bleeding complications later in disease
course 3,24. Therefore, in addition to routinely performed
laboratory plasma hemostasis tests we performed rotational
thrombelastometry (ROTEMW). Thromboelastometry records
the continuous proﬁles of whole blood coagulation by measure-
ment of the viscoelastic changes associated with ﬁbrin
polymerization, and thereby provides a global assessment of
hemostatic function 25.
Hemostatic function measured by thrombelastometry as well
as routinely performed plasma test such as activated partial
thromboplastin time and prothrombin time was found not
impaired in any of our 10 patients.
In conclusion, our results underline once more that the TBE
virus, despite being a member of ﬂavivirus family, has no
detectable inﬂuence on hemostasis and does not cause
clinically important bleeding complications. PET/CT revealed apredominance of hypometabolic but not TBE speciﬁc glucose
metabolism pattern. Although we could not identify a clear TBE
speciﬁc pattern, these ﬁndings may provide important informa-
tion regarding pathophysiologic mechanisms of TBE infection.
Glucose hypometabolism may reﬂect neuronal dysfunction in
predilection areas of TBE virus inﬁltration responsible for
development of clinical signs and symptoms. Further investiga-
tions in bigger cohorts are needed to deﬁne whether this
hypometabolism represents functional inactivation or irrevers-
ible brain damage.
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Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ijid.2016.06.022.
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